Contact
searchSearch
HMP Global

Psoriasis NPF Endorsed Features

NPF Endorsed Features
Understanding Generalized Pustular Psoriasis
12/05/2023
Proper evaluation and history collection are essential for accurate diagnosis and timely treatment.
Proper evaluation and history collection are essential for accurate diagnosis and timely treatment.
Proper evaluation and history...
12/05/2023
The Dermatologist
skin of color
NPF Endorsed Features
Psoriasis and Skin of Color
05/09/2023
Increased awareness of the nuances of diagnosing and treating patients with skin of color can improve training and research and help inform management.
Increased awareness of the nuances of diagnosing and treating patients with skin of color can improve training and research and help inform management.
Increased awareness of the...
05/09/2023
Dermatology

Popular Articles

News
Increased Risk of Inflammatory Arthritis and Spondyloarthritis in Patients With HS
04/13/2021
Patients with hidradenitis suppurativa (HS) have an increased risk of developing inflammatory arthritis, according to a recent study published in Dermatology.
Patients with hidradenitis suppurativa (HS) have an increased risk of developing inflammatory arthritis, according to a recent study published in Dermatology.
Patients with hidradenitis...
04/13/2021
The Dermatologist
News
Flare Outbreak of Hidradenitis Suppurativa Associated With Response to Adalimumab
07/11/2021
Flare outbreaks in patients with hidradenitis suppurativa (HS) are a predictive factor of response to adalimumab according to researchers out of Italy.
Flare outbreaks in patients with hidradenitis suppurativa (HS) are a predictive factor of response to adalimumab according to researchers out of Italy.
Flare outbreaks in patients with...
07/11/2021
The Dermatologist
News
Study Finds Biologic Use Associated With PsA Development
11/10/2021
A retrospective cohort study found that biologic use was associated with psoriatic arthritis (PsA) among patients with psoriasis.
A retrospective cohort study found that biologic use was associated with psoriatic arthritis (PsA) among patients with psoriasis.
A retrospective cohort study...
11/10/2021
The Dermatologist
Roundtable AAD
Videos
Expert Roundtable: Insights Into Atopic Dermatitis Following AAD
08/15/2022
In this video, live at the 2022 AAD Annual Meeting, Drs Paller, Friedman, Kwatra, and Blauvelt held a discussion atopic dermatitis following conference.
In this video, live at the 2022 AAD Annual Meeting, Drs Paller, Friedman, Kwatra, and Blauvelt held a discussion atopic dermatitis following conference.
In this video, live at the 2022...
08/15/2022
The Dermatologist
skin cancer
AAD Conference Preview: Topical and Intralesional Therapy
03/17/2023
In this feature interview, Dr Stacy McMurray discussed her session, “Topical and Intralesional Therapy,” before its presentation at the 2023 AAD Annual Meeting.
In this feature interview, Dr Stacy McMurray discussed her session, “Topical and Intralesional Therapy,” before its presentation at the 2023 AAD Annual Meeting.
In this feature interview, Dr...
03/17/2023
Dermatology

Sign Up for eNews!

Dermatology Newsletter

Dermatology News

psoriasis
News
Apremilast for Pediatric Patients With Moderate To Severe Plaque Psoriasis
09/11/2024
Researchers aimed to evaluate the efficacy and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis.
Researchers aimed to evaluate the efficacy and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis.
Researchers aimed to evaluate...
09/11/2024
Dermatology
psoriasis
News
Baseline Score on the Validated Psoriasis Symptoms and Signs Diary
08/22/2024
Researchers aimed to establish meaningful within-patient score change thresholds on the Psoriasis Symptoms and Signs Diary.
Researchers aimed to establish meaningful within-patient score change thresholds on the Psoriasis Symptoms and Signs Diary.
Researchers aimed to establish...
08/22/2024
Dermatology
psoriasis
News
Apremilast for Patients with Moderate to Severe Genital Psoriasis
08/09/2024
Researchers aimed to evaluate the efficacy and safety of apremilast 30 mg twice daily in patients with genital psoriasis.
Researchers aimed to evaluate the efficacy and safety of apremilast 30 mg twice daily in patients with genital psoriasis.
Researchers aimed to evaluate...
08/09/2024
Dermatology
psoriasis
News
Dermoscopy in Psoriasis: Clinical Value
07/24/2024
Dermoscopy has gained significant attention for its utility in evaluating inflammatory skin diseases, such as psoriasis.
Dermoscopy has gained significant attention for its utility in evaluating inflammatory skin diseases, such as psoriasis.
Dermoscopy has gained...
07/24/2024
Dermatology
psoriasis
News
Psoriasis as a Systemic Disease: Evidence and Management
07/09/2024
Researchers explored the pathophysiologic relationship between psoriasis and its common comorbidities.
Researchers explored the pathophysiologic relationship between psoriasis and its common comorbidities.
Researchers explored the...
07/09/2024
Dermatology
psoriasis
News
Cardiovascular Risk Assessment in Psoriasis
06/20/2024
Researchers aimed to evaluate cardiovascular risk in Slovak patients with psoriasis and investigate the relationship between cardiovascular risk and psoriasis features.
Researchers aimed to evaluate cardiovascular risk in Slovak patients with psoriasis and investigate the relationship between cardiovascular risk and psoriasis features.
Researchers aimed to evaluate...
06/20/2024
Dermatology
psoriasis
News
Nail Psoriasis Association With IL-17
06/07/2024
Researchers aimed to evaluate serum levels of inflammatory cytokines, specifically tumor necrosis factor-alpha and IL-17, in patients with nail psoriasis.
Researchers aimed to evaluate serum levels of inflammatory cytokines, specifically tumor necrosis factor-alpha and IL-17, in patients with nail psoriasis.
Researchers aimed to evaluate...
06/07/2024
Dermatology
psoriasis
News
Bibliometric Analysis of Metabolomics Trends in Psoriasis
05/13/2024
Researchers conducted a bibliometric analysis of publications on metabolomics in psoriasis from 2011 to 2024.
Researchers conducted a bibliometric analysis of publications on metabolomics in psoriasis from 2011 to 2024.
Researchers conducted a...
05/13/2024
Dermatology
psoriasis
News
Determining the Risk Factors for Joint Damage in Psoriasis
05/01/2024
Researchers aimed to address the need for early detection of psoriatic arthritis in patients with psoriasis.
Researchers aimed to address the need for early detection of psoriatic arthritis in patients with psoriasis.
Researchers aimed to address the...
05/01/2024
Dermatology
psoriasis
News
CD6-ALCAM Polymorphisms Potentially Modulate Psoriasis Risk and Outcomes
04/24/2024
Researchers aimed to investigate the potential association between polymorphisms in CD6 and ALCAM genes and susceptibility to psoriasis vulgaris.
Researchers aimed to investigate the potential association between polymorphisms in CD6 and ALCAM genes and susceptibility to psoriasis vulgaris.
Researchers aimed to investigate...
04/24/2024
Dermatology

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use